Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 4
2015 2
2016 2
2017 1
2018 1
2019 1
2020 5
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean maria martell (24 results)?
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
Zannetti BA, Tacchetti P, Pantani L, Gamberi B, Tosi P, Rocchi S, Cellini C, Ronconi S, Pezzi A, Mancuso K, Rizzello I, Caratozzolo I, Martello M, Dozza L, Cavo M, Zamagni E. Zannetti BA, et al. Among authors: martello m. Ann Hematol. 2017 Dec;96(12):2071-2078. doi: 10.1007/s00277-017-3140-5. Epub 2017 Oct 24. Ann Hematol. 2017. PMID: 29063955 Clinical Trial.
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma.
Mancuso K, Tacchetti P, Pantani L, Rocchi S, Rizzello I, Caratozzolo I, De Cicco G, Fusco A, Testoni N, Terragna C, Marzocchi G, Martello M, Borsi E, Dozza L, Cavo M, Zamagni E. Mancuso K, et al. Among authors: martello m. Bone Marrow Transplant. 2020 Sep;55(9):1865-1867. doi: 10.1038/s41409-020-0844-2. Epub 2020 Feb 26. Bone Marrow Transplant. 2020. PMID: 32103147 No abstract available.
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.
Ziccheddu B, Biancon G, Bagnoli F, De Philippis C, Maura F, Rustad EH, Dugo M, Devecchi A, De Cecco L, Sensi M, Terragna C, Martello M, Bagratuni T, Kastritis E, Dimopoulos MA, Cavo M, Carniti C, Montefusco V, Corradini P, Bolli N. Ziccheddu B, et al. Among authors: martello m. Blood Adv. 2020 Mar 10;4(5):830-844. doi: 10.1182/bloodadvances.2019000779. Blood Adv. 2020. PMID: 32126144 Free PMC article.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Rocchi S, Tacchetti P, Pantani L, Mancuso K, Rizzello I, di Giovanni Bezzi C, Scalese M, Dozza L, Marzocchi G, Martello M, Barilà G, Antonioli E, Staderini M, Buda G, Petrini M, Cea M, Quaresima M, Furlan A, Bonalumi A, Cavo M, Zamagni E. Rocchi S, et al. Among authors: martello m. Hematol Oncol. 2021 Feb;39(1):41-50. doi: 10.1002/hon.2820. Epub 2020 Nov 1. Hematol Oncol. 2021. PMID: 33085797 Clinical Trial.
Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models.
Borsi E, Martello M, Santacroce B, Zamagni E, Tacchetti P, Pantani L, Mancuso K, Rocchi S, Cavo M, Terragna C. Borsi E, et al. Among authors: martello m. Haematologica. 2018 Dec;103(12):e602-e606. doi: 10.3324/haematol.2017.186924. Epub 2018 Jul 19. Haematologica. 2018. PMID: 30026343 Free PMC article. No abstract available.
17 results